help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colston, K.
Right arrow Articles by Feldman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colston, K.
Right arrow Articles by Feldman, D.

Endocrinology, Vol 108, 1083-1086, Copyright © 1981 by Endocrine Society

ARTICLES

1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture

K Colston, MJ Colston and D Feldman

In this study we demonstrate the presence of specific, high-affinity receptors for 1,25-dihydroxyvitamin D3 in malignant melanoma. Receptors are present both in cultured melanoma cells and in melanoma tumor tissue produced by inoculation of cells into athymic rats. The receptor sediments at 3.25 on sucrose density gradients, possesses a preferential affinity for 1,25-(OH)2D3 and has an apparent Kd of 0.18 nM by Scatchard analysis. We also demonstrate that human melanoma cells are responsive to 1,25-(OH)2D3 in vitro. Inclusion of 1,25-(OH)2D3 in the culture medium produced a marked increase in cell doubling time. This inhibitory effect of the hormone on melanoma cell proliferation was dose-related and represents the first demonstration of a 1,25- (OH)2D3 mediated action on tumor cells.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
M. G. Fakih, D. L. Trump, J. R. Muindi, J. D. Black, R. J. Bernardi, P. J. Creaven, J. Schwartz, M. G. Brattain, A. Hutson, R. French, et al.
A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors
Clin. Cancer Res., February 15, 2007; 13(4): 1216 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
G. G. Schwartz and W. J. Blot
Vitamin d status and cancer incidence and mortality: something new under the sun.
J Natl Cancer Inst, April 5, 2006; 98(7): 428 - 430.
[Full Text] [PDF]

Home page
 Integr Cancer TherHome page
M. Uzick
Naturopathic Approaches
Integr Cancer Ther, September 1, 2005; 4(3): 253 - 258.
[PDF]

Home page
 Mol. Pharmacol.Home page
R. S. Savkur, K. S. Bramlett, K. R. Stayrook, S. Nagpal, and T. P. Burris
Coactivation of the Human Vitamin D Receptor by the Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1 {alpha}
Mol. Pharmacol., August 1, 2005; 68(2): 511 - 517.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
K. M. Egan, J. A. Sosman, and W. J. Blot
Sunlight and Reduced Risk of Cancer: Is The Real Story Vitamin D?
J Natl Cancer Inst, February 2, 2005; 97(3): 161 - 163.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
M. D. Gross
Vitamin D and Calcium in the Prevention of Prostate and Colon Cancer: New Approaches for the Identification of Needs
J. Nutr., February 1, 2005; 135(2): 326 - 331.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. D. Bikle
Vitamin D and Skin Cancer
J. Nutr., December 1, 2004; 134(12): 3472S - 3478S.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
A. Slominski, D. J. Tobin, S. Shibahara, and J. Wortsman
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
Physiol Rev, October 1, 2004; 84(4): 1155 - 1228.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
D. M. Albert, A. Kumar, S. A. Strugnell, S. R. Darjatmoko, J. M. Lokken, M. J. Lindstrom, C. M. Damico, and S. Patel
Effectiveness of 1{alpha}-Hydroxyvitamin D2 in Inhibiting Tumor Growth in a Murine Transgenic Pigmented Ocular Tumor Model
Arch Ophthalmol, September 1, 2004; 122(9): 1365 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. E. Millen, M. A. Tucker, P. Hartge, A. Halpern, D. E. Elder, D. Guerry IV, E. A. Holly, R. W. Sagebiel, and N. Potischman
Diet and Melanoma in a Case-Control Study
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 1042 - 1051.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. M. Beer and A. Myrthue
Calcitriol in cancer treatment: From the lab to the clinic
Mol. Cancer Ther., March 1, 2004; 3(3): 373 - 381.
[Abstract] [Full Text]

Home page
 IOVSHome page
I. Audo, S. R. Darjatmoko, C. L. Schlamp, J. M. Lokken, M. J. Lindstrom, D. M. Albert, and R. W. Nickells
Vitamin D Analogues Increase p53, p21, and Apoptosis in a Xenograft Model of Human Retinoblastoma
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4192 - 4199.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Pepper, A. Thomas, T. Hoy, D. Milligan, P. Bentley, and C. Fegan
The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro
Blood, April 1, 2003; 101(7): 2454 - 2459.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Kamao, S. Tatematsu, S. Hatakeyama, K. Ozono, N. Kubodera, G. S. Reddy, and T. Okano
Two Novel Metabolic Pathways of 22-Oxacalcitriol (OCT). C-25 DEHYDRATION AND C-3 EPIMERIZATION AND BIOLOGICAL ACTIVITIES OF NOVEL OCT METABOLITES
J. Biol. Chem., January 10, 2003; 278(3): 1463 - 1471.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T. M. Beer, K. M. Eilers, M. Garzotto, M. J. Egorin, B. A. Lowe, and W. D. Henner
Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer
J. Clin. Oncol., January 1, 2003; 21(1): 123 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. Gurlek, M. R. Pittelkow, and R. Kumar
Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation
Endocr. Rev., December 1, 2002; 23(6): 763 - 786.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. M. Zinser, J. P. Sundberg, and J. Welsh
Vitamin D3 receptor ablation sensitizes skin to chemically induced tumorigenesis
Carcinogenesis, December 1, 2002; 23(12): 2103 - 2109.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
T. Gaschott, D. Steinhilber, V. Milovic, and J. Stein
Tributyrin, a Stable and Rapidly Absorbed Prodrug of Butyric Acid, Enhances Antiproliferative Effects of Dihydroxycholecalciferol in Human Colon Cancer Cells
J. Nutr., June 1, 2001; 131(6): 1839 - 1843.
[Abstract] [Full Text]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. A. Platz, S. E. Hankinson, B. W. Hollis, G. A. Colditz, D. J. Hunter, F. E. Speizer, and E. Giovannucci
Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Adenomatous Polyps of the Distal Colorectum
Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1059 - 1065.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Cell Physiol.Home page
K. El Abdaimi, V. Papavasiliou, D. Goltzman, and R. Kremer
Expression and regulation of parathyroid hormone-related peptide in normal and malignant melanocytes
Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1230 - C1238.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. E. Hutchinson, J. E. Osborne, J. T. Lear, A. G. Smith, P. W. Bowers, P. N. Morris, P. W. Jones, C. York, R. C. Strange, and A. A. Fryer
Vitamin D Receptor Polymorphisms Are Associated with Altered Prognosis in Patients with Malignant Melanoma
Clin. Cancer Res., February 1, 2000; 6(2): 498 - 504.
[Abstract] [Full Text]

Home page
 J. Am. Coll. Nutr.Home page
M. Lipkin and H. L. Newmark
Vitamin D, Calcium and Prevention of Breast Cancer: A Review
J. Am. Coll. Nutr., October 1, 1999; 18(90005): 392S - 397.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. E. Abdaimi, V. Papavasiliou, S. A. Rabbani, J. S. Rhim, D. Goltzman, and R. Kremer
Reversal of Hypercalcemia with the Vitamin D Analogue EB1089 in a Human Model of Squamous Cancer
Cancer Res., July 1, 1999; 59(14): 3325 - 3328.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Yang and L. P. Freedman
20-Epi Analogues of 1,25-Dihydroxyvitamin D3 Are Highly Potent Inducers of DRIP Coactivator Complex Binding to the Vitamin D3 Receptor
J. Biol. Chem., June 11, 1999; 274(24): 16838 - 16845.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. C. Smith, C. S. Johnson, C. C. Freeman, J. Muindi, J. W. Wilson, and D. L. Trump
A Phase I Trial of Calcitriol (1,25-Dihydroxycholecalciferol) in Patients with Advanced Malignancy
Clin. Cancer Res., June 1, 1999; 5(6): 1339 - 1345.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
T. D. Veenstra, M. R. Pittelkow, and R. Kumar
Regulation of Cellular Growth by 1,25-Dihydroxyvitamin D3-Mediated Growth Factor Expression
Physiology, February 1, 1999; 14(1): 37 - 40.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. LIPKIN
Preclinical and Early Human Studies of Calcium and Colon Cancer Prevention
Ann. N.Y. Acad. Sci., January 1, 1999; 889(1): 120 - 127.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
M. Friedrich, L. Rafi, W. Tilgen, W. Schmidt, and J. Reichrath
Expression of 1,25-Dihydroxy Vitamin D3 Receptor in Breast Carcinoma
J. Histochem. Cytochem., November 1, 1998; 46(11): 1335 - 1338.
[Abstract] [Full Text]

Home page
 ScienceHome page
N. Morrison, J Shine, J. Fragonas, V Verkest, M. McMenemy, and J. Eisman
1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene
Science, December 1, 1989; 246(4934): 1158 - 1161.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society